Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RIF vs ATO in Pediatric APL
NCT02200978Phase 4Completed
- Sponsor
- South China Children's Leukemia Group
- Start
- Sep 2011
- Primary completion
- Oct 2021
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 4 trial of Compound Huangdai Tablet in acute promyelocytic leukemia (APL), sponsored by South China Children's Leukemia Group. Started Sep 2011; status: completed.
02
Drugs
Compound Huangdai Tablet
03
Conditions
acute promyelocytic leukemia (APL)
Beyond the preview
Go deeper on NCT02200978.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02200978.